Home	Fast Track My Amedeo FAQ About	Flying Publisher
Fast Track	FPG #8: Alternative Treatments in Psychiatry FPG #7: Critical Care in Neurology	Free Medical Books

Malignant Lymphoma

Free Subscription Articles published in Leuk Lymphoma Retrieve available abstracts of 307 articles: HTML format Text format

Single Articles

January 2012
1. WRIGHT TM , Rule S, Liu H, Du MQ, et al
   Extranodal Marginal Zone Lymphoma of the Uterine Corpus.
   Leuk Lymphoma. 2012.
   PubMed     Text format     Related articles   
   
   
   
   
2. CHEN AB , Feng Y, Neuberg D, Recklitis C, et al
   Employment and Insurance in Survivors of Hodgkin Lymphoma and Their Siblings: A Questionnaire Stud.
   Leuk Lymphoma. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
3. GOTO N , Tsurumi H, Takemura M, Kanemura N, et al
   Serum soluble CD27 level is associated with outcome in diffuse large B-cell lymphoma patients treated with R-CHOP.
   Leuk Lymphoma. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
4. DIMOU M , Angelopoulou M, Pangalis G, Georgiou G, et al
   AUTOIMMUNE HEMOLYTIC ANEMIA AND AUTOIMMUNE THROMBOCYTOPENIA AT DIAGNOSIS AND DURING FOLLOW-UP OF HODGKIN LYMPHOMA.
   Leuk Lymphoma. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
5. KIM SJ , Moon JH, Kim H, Kim JS, et al
   Non-bacterial infections in Asian patients treated with alemtuzumab: A retrospective study of the Asian Lymphoma Study Group.
   Leuk Lymphoma. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
6. KIM JH , Kim WS, Park C
   Epstein-Barr virus LMP1 protect B cell lymphoma from rituximab-induced apoptosis through miR-155-mediated Akt activation and up-regulation of Mcl-1.
   Leuk Lymphoma. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
7. ELSTROM RL , Andemariam B, Martin P, Ruan J, et al
   Bortezomib in combination with R-DICE chemoimmunotherapy (VIPER) in patients with relapsed and primary refractory diffuse large B cell lymphoma.
   Leuk Lymphoma. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
8. CABRERA ME , Martinez V, Nathwani BN, Konrad Muller-Hermelink H, et al
   Non-Hodgkin lymphoma in Chile. A review of 207 consecutive adult cases by a panel of five expert hematopathologists.
   Leuk Lymphoma. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
9. PROCHAZKA V , Faber E, Raida L, Langova K, et al
   High baseline serum thymidine kinase 1 level predicts unfavorable outcome in patients with follicular lymphoma.
   Leuk Lymphoma. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
10. THOENNISSEN NH , Thoennissen GB, Abbassi S, Nabavi-Nouis S, et al
    The transcription factor C/EBPalpha and critical circadian clock downstream target gene, PER2, are highly deregulated in diffuse large B-cell lymphoma.
    Leuk Lymphoma. 2012.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
11. HUNTINGTON SF , Talbott MS, Greer JP, Morgan DS, et al
    Toxicities and Outcomes among Septuagenarians and Octogenarians with Diffuse Large B cell Lymphoma Treated with Rituximab-CHOP Therapy.
    Leuk Lymphoma. 2012.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
12. CAJAIBA MM , Kahwash SB
    Interfollicular Hodgkin Lymphoma in Children: an Uncommon Mimicker of Reactive Lymphadenopathy.
    Leuk Lymphoma. 2012.
    PubMed     Text format     Related articles   
    
    
    
    
13. CHANDRAN R , Gardiner SK, Simon M, Spurgeon SE, et al
    Survival trends in Mantle cell lymphoma in the United States over sixteen years 1992-2007.
    Leuk Lymphoma. 2012.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
14. KAKUGAWA Y , Terasaka S, Watanabe T, Tanaka S, et al
    Enteropathy-associated T-cell lymphoma in small intestine detected by capsule endoscopy.
    Leuk Lymphoma. 2012.
    PubMed     Text format     Related articles   
    
    
    
    
15. DUMMER R , Beyer M, Hymes K, Epping MT, et al
    Vorinostat combined with bexarotene for the treatment of cutaneous T-cell lymphoma: in vitro and phase I clinical evidence supporting augmentation of RAR/RXR activation by histone deacetylase inhibition.
    Leuk Lymphoma. 2012.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
16. DICKINSON M
    Is autologous transplantation for transformed follicular lymphoma still justifiable?
    Leuk Lymphoma. 2012.
    PubMed     Text format     Related articles   
    
    
    
    
17. ITO D , Frantz AM, Williams C, Thomas R, et al
    CD40 ligand is necessary and sufficient to support primary diffuse large B-cell lymphoma cells in culture: a tool for in vitro preclinical studies with primary B-cell malignancies.
    Leuk Lymphoma. 2012.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
18. CHANG JE , Kahl BS
    Bendamustine: more ammunition in the battle against mantle cell lymphoma.
    Leuk Lymphoma. 2012.
    PubMed     Text format     Related articles   
    
    
    
    December 2011
19. CAMPBELL P , Friebe A, Foulstone P, Grigg A, et al
    Impact of palifermin on mucosal toxicity in autologous stem cell transplants using busulfan-melphalan conditioning chemotherapy for Hodgkin and non-Hodgkin lymphoma.
    Leuk Lymphoma. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
20. WARSCH S , Hosein PJ, Maeda LS, Alizadeh AA, et al
    A retrospective study evaluating the efficacy and safety of bendamustine in the treatment of mantle cell lymphoma.
    Leuk Lymphoma. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
21. GUISADO-VASCO P , Arranz R, Canales M, Canovas A, et al
    Stage IV and age over 45 years are the only prognostic factors of the International Prognostic Score (IPS) for the outcome of advanced Hodgkin Lymphoma in the Spanish Hodgkin Lymphoma Study Group series.
    Leuk Lymphoma. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
22. ROSKO A , Lazarus HM
    Salvage chemotherapy and autologous hematopoietic cell transplantation (AHCT) in primary refractory diffuse large B-cell lymphoma (DLBCL): Progress or better patient selection?
    Leuk Lymphoma. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
23. EICHENAUER DA , Borchmann P, Engert A
    Adolescents with Hodgkin lymphoma - old children or young adults?
    Leuk Lymphoma. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
24. ANASTASI J
    Everything has its place...or so we thought: NK/T cell lymphoma, nasal type in the testes.
    Leuk Lymphoma. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
25. LAFFON M , Giordana C, Almairac F, Benchetrit M, et al
    Letter to the editor: Anti-Hu-Associated paranaeoplastic limbic encephalitis in hodgkin lymphoma.
    Leuk Lymphoma. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
26. LIANG DN , Yang ZR, Wang WY, Zhao S, et al
    Extranodal nasal type NK/T-cell lymphoma of testis: report of seven cases with review of literature.
    Leuk Lymphoma. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
27. JONES JA
    Weight gain after lymphoma treatment: fat or fiction?
    Leuk Lymphoma. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
28. ANDERLINI P , Saliba R, Acholonu S, Okoroji GJ, et al
    Donor leukocyte infusions (DLIs) in recurrent hodgkin lymphoma (HL) following allogeneic stem cell transplantation: ten-year experience at the M.D. anderson cancer center.
    Leuk Lymphoma. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
29. SHARMA R , Vinayak M
    Antioxidant alpha- tocopherol checks lymphoma promotion via regulation of expression of PKC-alpha, c-Myc genes and glycolytic metabolism.
    Leuk Lymphoma. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
30. LOPEZ-GUILLERMO A , Caballero D, Canales M, Provencio M, et al
    Clinical practice guidelines for first-line/after-relapse treatment of patients with follicular lymphoma.
    Leuk Lymphoma. 2011;52 Suppl 3:1-14.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    November 2011
31. NINOMIYA S , Hara T, Tsurumi H, Goto N, et al
    Indoleamine 2,3-dioxygenase expression and serum kynurenine concentrations in patients with diffuse large B-cell lymphoma.
    Leuk Lymphoma. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
32. JOHNSEN H , Haioun C, Lugtenburg P, Salar A, et al
    The importance of G-CSF prophylaxis in R-CHOP-14 therapy for diffuse large B-cell lymphoma in routine clinical practice.
    Leuk Lymphoma. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
33. WIERNIK PH , Li H, Weller E, Hochster HS, et al
    Activity of Topotecan 21-Day Infusion in Patients with Previously Treated Large Cell Lymphoma: Long-term follow-up of an Eastern Cooperative Oncology Group Study (E5493).
    Leuk Lymphoma. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
34. ABEL GA , Vanderplas A, Rodriguez MA, Crosby AL, et al
    High Rates of Surveillance Imaging for Treated Diffuse Large B-Cell Lymphoma: Findings from a Large National Database.
    Leuk Lymphoma. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
35. WILCOX RA , Ristow K, Habermann TM, Inwards DJ, et al
    The Absolute Monocyte Count is Associated with Overall Survival in Patients Newly Diagnosed with Follicular Lymphoma.
    Leuk Lymphoma. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
36. MELZER N , Barth PJ, Muller KM, Foss HD, et al
    Rapidly progressive B-cell dominated inflammatory neuropathy and littoral cell angioma of the spleen associated with plasmablastic B-cell lymphoma.
    Leuk Lymphoma. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
37. CERHAN JR , Natkunam Y, Morton LM, Maurer MJ, et al
    LMO2 protein expression, LMO2 germline genetic variation, and overall survival in diffuse large B-cell lymphoma in the pre-rituximab era.
    Leuk Lymphoma. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
38. ALADILLY T , Jeffrey Medeiros L, Alayed K, Miranda RN, et al
    Breast implant-associated anaplastic large cell lymphoma: A newly recognized entity that needs further refinement of its definition.
    Leuk Lymphoma. 2011.
    PubMed     Text format     Related articles   
    
    
    
    October 2011
39. YANG DH , Kim WS, Kim SJ, Kim JS, et al
    Pilot trial of yttrium-90 ((90)Y)-ibritumomab tiuxetan consolidation following R-CHOP chemotherapy in patients with limited-stage, bulky diffuse large B-cell lymphoma.
    Leuk Lymphoma. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
40. QI SN , Li YX, Wang WH, Jin J, et al
    The extent of cutaneous lesions predicts outcome in extranodal nasal-type NK/T-cell lymphoma of the upper aerodigestive tract with secondary cutaneous involvement.
    Leuk Lymphoma. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
41. ALIMOHAMED N , Daly A, Owen C, Duggan P, et al
    Thiotepa, busulfan, cyclophosphamide, and autologous stem cell transplantation for primary cns lymphoma: a single centre experience.
    Leuk Lymphoma. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
42. BATTY N , Hagemeister FB, Feng L, Romaguera JE, et al
    Doxorubicin, Bleomycin, Vinblastine, and Dacarbazine Chemotherapy with Interferon for Advanced Stage Classic Hodgkin's Lymphoma: A 10-Year Follow-up Study.
    Leuk Lymphoma. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
43. HOPP RN , Marchi MT, Kellermann MG, Rizo VH, et al
    Lymphoma mimicking a dental periapical lesion.
    Leuk Lymphoma. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
44. VALDEZ BC , Murray D, Nieto Y, Li Y, et al
    Synergistic cytotoxicity of the DNA alkylating agent busulfan, nucleoside analogs and SAHA in lymphoma cell lines.
    Leuk Lymphoma. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
45. SOHLBACH K , Moll R, Gossmann J, Nowak O, et al
    Beta-catenin signalling: no relevance in Hodgkin lymphoma?
    Leuk Lymphoma. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
46. BAN-HOEFEN M , Kelly JL, Bernstein SH, Liesveld J, et al
    High-dose therapy and autologous stem cell transplant for transformed non-Hodgkin lymphoma in the rituximab era.
    Leuk Lymphoma. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
47. HILL BT , Sweetenham J
    Clinical Implications of the Molecular Subtypes of Diffuse Large B-Cell Lymphoma.
    Leuk Lymphoma. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
48. OKI Y , Copeland A, Romaguera J, Fayad L, et al
    Clinical Experience with the Heat Shock Protein-90 inhibitor, Tanespimycin (17AAG), in Patients with Relapsed Lymphoma.
    Leuk Lymphoma. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
49. ZHANG X , Zhao L, Chen C, Yan J, et al
    The effect of lentivirus-mediated expression of TRAIL and shRNA against Bcl-2 on the growth of lymphoma cells.
    Leuk Lymphoma. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
50. HOFMAN MS
    FDG PET/CT for evaluation of bone marrow involvement in lymphoma: when is it superior to biopsy?
    Leuk Lymphoma. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
51. WYSOCKA M , Dawany N, Benoit B, Kossenkov AV, et al
    Synergistic enhancement of cellular immune responses by the novel Toll receptor 7/8 agonist 3M-007 and interferon-gamma: implications for therapy of cutaneous T-cell lymphoma.
    Leuk Lymphoma. 2011;52:1970-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
52. NG AK , Hodgson DC
    Is there a role for consolidative radiation therapy for aggressive B-cell lymphoma in the rituximab era?
    Leuk Lymphoma. 2011;52:1821-2.
    PubMed     Text format     Related articles   
    
    
    
    
53. GOY A
    Are we improving the survival of patients with mantle cell lymphoma: if so, what is the explanation?
    Leuk Lymphoma. 2011;52:1828-30.
    PubMed     Text format     Related articles   
    
    
    
    September 2011
54. AU WING Y , Wan Thomas SK, Leung Rock YY, Lie Albert KW, et al
    Sequential chronic myelogenous leukemia, B-lineage lymphoma and erythroleukemia with monosomy 7 over ten years.
    Leuk Lymphoma. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
55. NABHAN C , Smith SM, Kahl BS
    Maintenance Rituximab in Follicular Non-Hodgkin Lymphoma: Facts and Controversies.
    Leuk Lymphoma. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
56. BARBER NA , Loberiza FR
    Quality of Life after Chemotherapy or Hematopoietic Cell Transplantation in Follicular Lymphoma: What's Next?
    Leuk Lymphoma. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
57. YAMASHITA J , Iwamura C, Mitsumori K, Hosokawa H, et al
    Murine Schnurri-2 controls Natural Killer cell function and lymphoma development.
    Leuk Lymphoma. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
58. SHAFEY M , Duan Q, Russell J, Duggan P, et al
    Double high-dose therapy with dose-intensive cyclophosphamide, etoposide, cisplatin (DICEP) followed by high-dose melphalan and autologous stem cell transplantation for relapsed/refractory hodgkin lymphoma.
    Leuk Lymphoma. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
59. CARBONE A , Tibiletti MG, Canzonieri V, Rossi D, et al
    In situ follicular lymphoma associated with non lymphoid malignancies.
    Leuk Lymphoma. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
60. FOUKAS PG , Kefala M, Papageorgiou S, Tsirigotis P, et al
    CD20 expression in angioimmunoblastic T cell lymphoma.
    Leuk Lymphoma. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
61. PATKAR N , Nair S, Alex AA, Parihar M, et al
    Clinicopathological Features of Hepatosplenic T Cell Lymphoma: A Single Centre Experience from India.
    Leuk Lymphoma. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
62. ADVANI RH , Hong F, Horning SJ, Kahl BS, et al
    Cardiac Toxicity Associated with Bevacizumab (Avastin) in Combination with CHOP Chemotherapy for Peripheral T Cell Lymphoma in ECOG 2404 Trial.
    Leuk Lymphoma. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
63. MORABITO F , Hohaus S, Mammi C, Marcheselli L, et al
    Role of Glutathione-S-Transferase (GST) polymorphisms in patients with advanced Hodgkin Lymphoma: Results from the HD2000 GISL Trial.
    Leuk Lymphoma. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
64. WU X , Pertovaara H, Korkola P, Vornanen M, et al
    Glucose metabolism correlated with cellular proliferation in diffuse large B-cell lymphoma.
    Leuk Lymphoma. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
65. GIACHELIA M , Voso MT, Tisi MC, Martini M, et al
    Interleukin-6 Plasma Levels Are Modulated by a Polymorphism in the NFKB1 Gene and are Associated with Outcome Following Rituximab-Combined Chemotherapy in Diffuse Large B-Cell Non-Hodgkin Lymphoma.
    Leuk Lymphoma. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
66. LITWIN AS , Verity DH, Woodruff SA
    Epiphora as the presenting sign in unsuspected B cell lymphoma.
    Leuk Lymphoma. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
67. MERLI F , Luminari S, Rossi G, Mammi C, et al
    R-CHOP vs R-miniCEOP for the initial treatment of elderly "fit" patients with diffuse large B-cell lymphoma. Results from the ANZINTER3 trial of the Intergruppo Italiano Linfomi (IIL).
    Leuk Lymphoma. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
68. LYNCE F , Pehlivanova M, Catlett J, Malkovska V, et al
    Obesity In Adult Lymphoma Survivors.
    Leuk Lymphoma. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
69. SWEETENHAM JW , Polliack A
    Progressive transformation of germinal centers and Hodgkin lymphoma - more insights but maybe more confusion ?
    Leuk Lymphoma. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
70. MURINGAMPURATH-JOHN D , Flowers CR, Toscano M, Zhengjia C, et al
    Rituximab-HyperCVAD for aggressive Non-Hodgkin's Lymphoma.
    Leuk Lymphoma. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
71. KENKRE VP , Long WL, Eickhoff JC, Blank JH, et al
    Maintenance rituximab following induction chemo-immunotherapy for mantle cell lymphoma: long-term follow-up of a pilot study from the Wisconsin Oncology Network.
    Leuk Lymphoma. 2011;52:1675-1680.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
72. PERRY AM , Molina-Kirsch H, Nathwani BN, Diebold J, et al
    Classification of non-Hodgkin lymphomas in Guatemala according to the World Health Organization system.
    Leuk Lymphoma. 2011;52:1681-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    August 2011
73. CHOWDHURY A , Chowdhury S, Tsai MY
    A Novel Aurora Kinase A inhibitor MK-8745 predicts TPX2 as a therapeutic biomarker in Non-Hodgkin lymphoma cell lines.
    Leuk Lymphoma. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
74. VEZZOLI P , Novara F, Fanoni D, Gambini D, et al
    Three cases of primary cutaneous lymphoblastic lymphoma: microarray-based comparative genomic hybridization and gene expression profiling studies with review of literature.
    Leuk Lymphoma. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
75. RICHARDSON SE , Sudak J, Warbey V, Ramsay A, et al
    Routine bone marrow biopsy is not necessary in the staging of classical Hodgkin lymphoma patients in the FDG-PET era.
    Leuk Lymphoma. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
76. WY A , Ck Y, F L, Kh L, et al
    A gamma-delta T cell lymphoma with a mask face.
    Leuk Lymphoma. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
77. FOYIL KV , Kennedy DA, Grove LE, Bartlett NL, et al
    Extended Retreatment with Brentuximab Vedotin (SGN-35) Maintains Complete Remission in Patient with Recurrent Systemic Anaplastic Large-Cell Lymphoma.
    Leuk Lymphoma. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
78. MEGURO A , Ozaki K, Sato K, Oh I, et al
    Rituximab plus 70% cyclophosphamide, doxorubicin, vincristine and prednisone for Japanese patients with diffuse large B-cell lymphoma aged 70 years and older.
    Leuk Lymphoma. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
79. HASSELBLOM S , Stenson M, Werlenius O, Sender M, et al
    Improved outcome for very elderly patients with diffuse large B-cell lymphoma in the immunochemotherapy era.
    Leuk Lymphoma. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
80. REZANIA K , Soliven B, Baron J, Lin H, et al
    Myasthenia Gravis: An Autoimmune Manifestation of Lymphoma And Lymphoproliferative Disorders.
    Leuk Lymphoma. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
81. ANDRESEN S , Brandt J, Dietrich S, Memmer ML, et al
    The Impact of High- Dose Chemotherapy, Autologous Stem Cell Transplantation and Conventional Chemotherapy on Quality of life of Long Term Survivors with Follicular Lymphoma.
    Leuk Lymphoma. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
82. BONN BR , Krieger D, Burkhardt B
    Cell Cycle Regulatory Molecular Profiles of Pediatric T-Cell Lymphoblastic Leukemia and Lymphoma.
    Leuk Lymphoma. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
83. ANDERLINI P , Saliba RM, Ledesma C, Chancoco C, et al
    Gemcitabine, fludarabine and melphalan (G-FM) as a reduced-intensity conditioning regimen for allogeneic stem cell transplantation in relapsed and refractory hodgkin lymphoma: preliminary results.
    Leuk Lymphoma. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
84. RADWAN FF , Zhang L, Hossain A, Doonan BP, et al
    Mechanisms regulating enhanced HLA class II-mediated CD4+ T cell recognition of human B-cell lymphoma by resveratrol.
    Leuk Lymphoma. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
85. MORTON LM , Landgren O
    Associations between non-Hodgkin lymphoma and renal cell carcinoma.
    Leuk Lymphoma. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
86. DREYLING M , Kluin-Nelemans HC, Bea S, Hartmann E, et al
    Update on the molecular pathogenesis and clinical treatment of mantle cell lymphoma: report of the 10th annual conference of the European Mantle Cell Lymphoma Network.
    Leuk Lymphoma. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
87. DE BOER JP , Raderer M, van Tinteren H, Aleman BM, et al
    Treatment of extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma) with fludarabine: effect on tumor microenvironment.
    Leuk Lymphoma. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
88. COX MC , Ambrogi V, Lanni V, Cavalieri E, et al
    THE USE OF INTERIM 18FDG-PET IS NOT JUSTIFIED IN DIFFUSE LARGE B CELL LYMPHOMA (DLBCL) DURING FIRST LINE IMMUNO-CHEMOTHERAPY.
    Leuk Lymphoma. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
89. TSURUMI H , Hara T, Goto N, Kitagawa JI, et al
    A phase II study of rituximab combined with THP-COP regimen as a first-line therapy for patients with indolent B-cell lymphoma.
    Leuk Lymphoma. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
90. NEUBAUER A
    Gastric MALT lymphoma: How to attack the T... for two?
    Leuk Lymphoma. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
91. KIRSCHBAUM MH , Goldman BH, Zain JM, Cook JR, et al
    A Phase 2 Study of Vorinostat for Treatment of Relapsed or Refractory Hodgkin Lymphoma: Southwest Oncology Group Study S0517.
    Leuk Lymphoma. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
92. WANG L , Liu P, Geng Q, Chen X, et al
    Prognostic significance of neuron-specific enolase in patients with diffuse large B-cell lymphoma treated with rituximab-based immunochemotherapy.
    Leuk Lymphoma. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
93. HAWKES EA , Wotherspoon A, Cunningham D
    The unique entity of nodular lymphocyte-predominant Hodgkin lymphoma: Current approaches to diagnosis and management.
    Leuk Lymphoma. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
94. LEE HY , Kim SJ, Kim K, Ko YH, et al
    Bone involvement in patients with stage IV diffuse large B-cell lymphoma: Does it have a prognostic value?
    Leuk Lymphoma. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
95. BEAVEN AW , Shea TC, Moore DT, Feldman T, et al
    A Phase I study evaluating Ibritumomab Tiuxetan (Zevalin((R))) in combination with Bortezomib (Velcade((R))) in relapsed/refractory mantle cell and low grade B cell Non Hodgkin Lymphoma.
    Leuk Lymphoma. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
96. LANIC H , Mareschal S, Mechken F, Picquenot JM, et al
    Interim positron emission tomography scan associated with international prognostic index and germinal center B cell-like signature as prognostic index in diffuse large B-cell lymphoma.
    Leuk Lymphoma. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
97. AL-NAWAKIL C , Kosmider O, Stern MH, Manie E, et al
    Leukemic phase of follicular lymphomas: an atypical presentation.
    Leuk Lymphoma. 2011;52:1504-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    July 2011
98. LANDRIGAN A , Yiu G, Agarwal K, Utz PJ, et al
    Therapeutic TLR agonists directly influence mouse and human T cell lymphoma cell viability and cytokine secretion.
    Leuk Lymphoma. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
99. JOHRENS K , Dietel M, Anagnostopoulos I
    Three different expression patterns of T-bet in angioimmunoblastic T-cell lymphoma.
    Leuk Lymphoma. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
100. HUTCHINGS M
     Pre-transplant positron emission tomography/computed tomography (PET/CT) in relapsed Hodgkin lymphoma: time to shift gears for PET-positive patients?
     Leuk Lymphoma. 2011.
     PubMed     Text format     Related articles   
     
     
     
     
101. MISHRA S , Vinayak M
     Anti-carcinogenic action of ellagic acid mediated via modulation of oxidative stress regulated genes in Dalton lymphoma bearing mice.
     Leuk Lymphoma. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
102. ALDINUCCI D , Gloghini A, Pinto A, Colombatti A, et al
     The role of CD40/CD40L and Interferon Regulatory Factor 4 in Hodgkin lymphoma microenvironment.
     Leuk Lymphoma. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
103. GERRIE A , Toze C, Ramadan K, Li C, et al
     Oral fludarabine and rituximab as initial therapy for chronic lymphocytic leukemia or small lymphocytic lymphoma: population-based experience matches clinical trials.
     Leuk Lymphoma. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
104. CHEN WC , Sigal DS, Saven A, Paulson JC, et al
     Targeting B lymphoma with nanoparticles bearing glycan ligands of CD22.
     Leuk Lymphoma. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
105. LI W , Frame LT, Hoo KA, Li Y, et al
     Genistein inhibited proliferation and induced apoptosis in acute lymphoblastic leukemia, lymphoma and multiple myeloma cells in vitro.
     Leuk Lymphoma. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
106. MART N P , Salas C, Provencio M, Abraira V, et al
     Heterogeneous expression of Src tyrosine kinases Lyn, Fyn and Syk in classical Hodgkin lymphoma: prognostic implications.
     Leuk Lymphoma. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
107. BEVERIDGE R , Satram-Hoang S, Sail K, Darragh J, et al
     Economic impact of disease progression in follicular non-Hodgkin lymphoma.
     Leuk Lymphoma. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
108. CHIHARA D , Oki Y, Matsuo K, Onoda H, et al
     Incidence and risk factors for central nervous system relapse in patients with diffuse large B-cell lymphoma: analyses with competing risk regression model.
     Leuk Lymphoma. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
109. MITTAL BR , Manohar K, Malhotra P, Das R, et al
     Can fluorodeoxyglucose positron emission tomography/computed tomography avoid negative iliac crest biopsies in evaluation of marrow involvement by lymphoma at time of initial staging?
     Leuk Lymphoma. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
110. TIEMANN K , Alluin JV, Honegger A, Chomchan P, et al
     Small interfering RNAs targeting cyclin D1 and cyclin D2 enhance the cytotoxicity of chemotherapeutic agents in mantle cell lymphoma cell lines.
     Leuk Lymphoma. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
111. MOTOMURA K , Natsume A, Fujii M, Ito M, et al
     Long-term survival in patients with newly diagnosed primary central nervous system lymphoma treated with dexamethasone, etoposide, ifosfamide and carboplatin chemotherapy and whole-brain radiation therapy.
     Leuk Lymphoma. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
112. GO H , Cho HJ, Paik JH, Park CM, et al
     Thymic extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue: a clinicopathological and genetic analysis of six cases.
     Leuk Lymphoma. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
113. WIRTH A
     Primary Central Nervous System Lymphoma: The Challenge Continues.
     Leuk Lymphoma. 2011.
     PubMed     Text format     Related articles   
     
     
     
     
114. PETERS AC , Duan Q, Russell JA, Duggan P, et al
     Durable event-free survival following autologous stem cell transplant for relapsed or refractory follicular lymphoma: positive impact of recent rituximab exposure and low-risk Follicular Lymphoma International Prognostic Index score.
     Leuk Lymphoma. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
115. BLAES AH , Ma L, Zhang Y, Peterson BA, et al
     Quality of life appears similar between survivors of indolent and aggressive non-Hodgkin lymphoma.
     Leuk Lymphoma. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
116. MARKOVA J , Kahraman D, Kobe C, Skopalova M, et al
     The role of FDG-PET in early and late therapy assessment of patients with advanced Hodgkin Lymphoma treated with BEACOPP.
     Leuk Lymphoma. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
117. MINUK LA , Monkman K, Chin-Yee IH, Lazo-Langner A, et al
     Treatment of Hodgkin lymphoma with ABVD without routine G-CSF support does not increase the risk of febrile neutropenia: A prospective cohort study.
     Leuk Lymphoma. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
118. KOCH K , Klapper W
     Endogenous interferon alpha therapy in follicular lymphoma?
     Leuk Lymphoma. 2011;52:1168-9.
     PubMed     Text format     Related articles   
     
     
     
     
119. THOMAS R , Seiser EL, Motsinger-Reif A, Borst L, et al
     Refining tumor-associated aneuploidy through 'genomic recoding' of recurrent DNA copy number aberrations in 150 canine non-Hodgkin lymphomas.
     Leuk Lymphoma. 2011;52:1321-35.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     June 2011
120. PENNESE E , Vergine C, Matera R, Dargenio M, et al
     Complete response induced by fotemustine given as single agent in a patient with primary central nervous system non-Hodgkin aggressive lymphoma relapsed after high-dose chemotherapy and autologous stem cell support.
     Leuk Lymphoma. 2011.
     PubMed     Text format     Related articles   
     
     
     
     
121. SUBRAMANIYAM S , Fraser CR, Rao PH, Feldman E, et al
     De novo B lymphoblastic leukemia/lymphoma in an adult with t(14;18)(q32;q21) and c-MYC gene rearrangement involving 10p13.
     Leuk Lymphoma. 2011.
     PubMed     Text format     Related articles   
     
     
     
     
122. WASTERLID T , Jonsson B, Hagberg H, Jerkeman M, et al
     Population based study of prognostic factors and treatment in adult Burkitt lymphoma: a Swedish Lymphoma Registry study.
     Leuk Lymphoma. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
123. HONG J , Park S, Park J, Kim HS, et al
     Evaluation of prognostic values of clinical and histopathologic characteristics in diffuse large B-cell lymphoma treated with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone therapy.
     Leuk Lymphoma. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
124. VASTAGH I , Bereczki D, Varallyay G, Palasti A, et al
     Long-term clinical improvement of progressive multifocal leukoencephalopathy associated with prominent inflammatory response and follicular lymphoma.
     Leuk Lymphoma. 2011.
     PubMed     Text format     Related articles   
     
     
     
     
125. ABRAHAMSSON A , Dahle N, Jerkeman M
     Marked improvement of overall survival in mantle cell lymphoma: a population based study from the Swedish Lymphoma Registry.
     Leuk Lymphoma. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
126. EL-SHARKAWI D , Ramsay A, Cwynarski K, Hughes D, et al
     Clinico-pathologic characteristics of patients with hepatic lymphoma diagnosed using image-guided liver biopsy techniques.
     Leuk Lymphoma. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
127. KARMALI R , Larson ML, Wooldridge JE, Gregory SA, et al
     Granulocyte-macrophage colony stimulating factor-induced immune priming of cyclophosphamide, doxorubicin, vincristine, and prednisone with rituximab chemoimmunotherapy in previously untreated patients with diffuse large B-cell lymphoma and mantle cell
     Leuk Lymphoma. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
128. YANG SF , Chang WY, Lan CC, Isaacson PG, et al
     Composite primary cutaneous peripheral T-cell lymphoma and Epstein-Barr virus-positive large B-cell lymphoma.
     Leuk Lymphoma. 2011.
     PubMed     Text format     Related articles   
     
     
     
     
129. MORRIS PG , Abrey LE, Reiner AS, Wu N, et al
     Methotrexate area under the curve as a prognostic factor in primary central nervous system lymphoma treated with immunochemoradiotherapy.
     Leuk Lymphoma. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
130. SINGH AT , Ghosh M, Forte TM, Ryan RO, et al
     Curcumin nanodisk-induced apoptosis in mantle cell lymphoma.
     Leuk Lymphoma. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
131. POPPLEWELL L , Thomas SH, Huang Q, Chang KL, et al
     Primary anaplastic large-cell lymphoma associated with breast implants.
     Leuk Lymphoma. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
132. ZAIN J , Palmer JM, Delioukina M, Thomas S, et al
     Allogeneic hematopoietic cell transplant for peripheral T-cell non-Hodgkin lymphoma results in long-term disease control.
     Leuk Lymphoma. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
133. MOCIKOVA H , Pytlik R, Markova J, Steinerova K, et al
     Pre-transplant positron emission tomography in patients with relapsed Hodgkin lymphoma.
     Leuk Lymphoma. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
134. MARTIN P , Leonard JP
     Advancing through maintenance in mantle cell lymphoma.
     Leuk Lymphoma. 2011.
     PubMed     Text format     Related articles   
     
     
     
     
135. JAKOVIC LR , Mihaljevic BS, Perunicic Jovanovic MD, Bogdanovic AD, et al
     The prognostic relevance of tumor associated macrophages in advanced stage classical Hodgkin lymphoma.
     Leuk Lymphoma. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
136. PICARDI M , Zeppa P, Ciancia G, Pettinato G, et al
     Efficacy and safety of rituximab treatment in patients with progressive transformation of germinal centers after Hodgkin lymphoma in complete remission post-induction chemotherapy and radiotherapy.
     Leuk Lymphoma. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
137. FARRELL K , McKay P, Leach M
     Nodular lymphocyte predominant Hodgkin lymphoma behaves as a distinct clinical entity with good outcome: evidence from 14-year follow-up in the West of Scotland Cancer Network.
     Leuk Lymphoma. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
138. GERARD LM , Imrie KR, Mangel J, Buckstein R, et al
     High-dose methotrexate based chemotherapy with deferred radiation for treatment of newly diagnosed primary central nervous system lymphoma.
     Leuk Lymphoma. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
139. LUMINARI S , Cesaretti M, Tomasello C, Guida A, et al
     Use of 2-[(18)F]fluoro-2-deoxy-D-glucose positron emission tomography in patients with Hodgkin lymphoma in daily practice: a population-based study from Northern Italy.
     Leuk Lymphoma. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
140. MARCHESELLI L , Marcheselli R, Bari A, Liardo E, et al
     Radiation therapy improves treatment outcome in patients with diffuselarge B-cell lymphoma.
     Leuk Lymphoma. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
141. BASAK GW , Mikala G, Koristek Z, Jaksic O, et al
     Plerixafor to rescue failing chemotherapy-based stem cell mobilization: it's not too late.
     Leuk Lymphoma. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
142. PICCALUGA PP , Pileri SA, Agostinelli C, Klapper W, et al
     Follicular lymphoma: still Six characters in search of an author?
     Leuk Lymphoma. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
143. JOERGER M , Huitema AD, Illerhaus G, Ferreri AJ, et al
     High-dose methotrexate in patients with primary central nervous system lymphoma: does drug exposure really matter?
     Leuk Lymphoma. 2011.
     PubMed     Text format     Related articles   
     
     
     
     
144. LIU H , Cai P, Liu HX, Wang JL, et al
     Vaccination with immunoglobulin frame region-derived nonapeptide elicits cellular immune response against lymphoma in human leukocyte antigen-A2.1 transgenic mice.
     Leuk Lymphoma. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
145. TADMOR T , Polliack A
     Mantle cell lymphoma: curcumin nanodisks and possible new concepts on drug delivery for an incurable lymphoma.
     Leuk Lymphoma. 2011.
     PubMed     Text format     Related articles   
     
     
     
     
146. FABISIEWICZ A , Paszkiewicz-Kozik E, Osowiecki M, Walewski J, et al
     FcgammaRIIA and FcgammaRIIIA polymorphisms do not influence survival and response to rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone immunochemotherapy in patients with diffuse large B-cell lymphoma.
     Leuk Lymphoma. 2011.
     PubMed     Text format     Related articles   
     
     
     
     
147. XUAN KOO Y , Tan DS, Tan IB, Tai DW, et al
     Effect of concomitant statin, metformin, or aspirin on rituximab treatment for diffuse large B-cell lymphoma.
     Leuk Lymphoma. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
148. YAMAMOTO J , Fujishima F, Ichinohasama R, Imatani A, et al
     A case of benign natural killer cell proliferative disorder of the stomach (gastric manifestation of natural killer cell lymphomatoid gastroenteropathy) mimicking extranodal natural killer/T-cell lymphoma.
     Leuk Lymphoma. 2011.
     PubMed     Text format     Related articles   
     
     
     
     
149. MIWA A , Sekiguchi N, Tanimura A, Homma C, et al
     Ranimustine, ifosfamide, procarbazine, dexamethasone, and etoposide therapy for central nervous system recurrence of diffuse large B-cell lymphoma in patients with poor performance status: a pilot study.
     Leuk Lymphoma. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
150. QUERFELD C , Kuzel TM, Kim YH, Porcu P, et al
     Multicenter phase II trial of enzastaurin in patients with relapsed or refractory advanced cutaneous T-cell lymphoma.
     Leuk Lymphoma. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
151. HASEGAWA H , Komoda M, Yamada Y, Yonezawa S, et al
     Aberrant overexpression of membrane-associated mucin contributes to tumor progression in adult T-cell leukemia/lymphoma cells.
     Leuk Lymphoma. 2011;52:1108-17.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
152. JUNG HJ , Chen Z, McCarty N
     Stem-like tumor cells confer drug resistant properties to mantle cell lymphoma.
     Leuk Lymphoma. 2011;52:1066-79.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
153. HUANG H , Lin Z, Lin X, Cai Q, et al
     Long-term outcomes of patients with newly diagnosed extranodal natural killer/T-cell lymphoma treated by etoposide, prednisone, vincristine, cyclophosphamide, and doxorubicin regimen: a single-institution experience.
     Leuk Lymphoma. 2011;52:1041-8.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
154. RAMSDALE E , Smith S
     Old versus frail: why it matters in lymphoma.
     Leuk Lymphoma. 2011;52:938-3940.
     PubMed     Text format     Related articles   
     
     
     
     
155. RAMSDALE E , Van Besien K
     Allogeneic transplant for peripheral T-cell lymphoma: a sparkle of hope and many questions.
     Leuk Lymphoma. 2011;52:938-40.
     PubMed     Text format     Related articles   
     
     
     
     
156. HERBERT KE , Ritchie DS, Seymour JF
     Strategies to optimize collection of hematopoietic stem cells in patients with mantle cell lymphoma receiving hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone combined with cytarabine and methotrexate-chemotherapy.
     Leuk Lymphoma. 2011;52:935-7.
     PubMed     Text format     Related articles   
     
     
     
     
157. NEGAARD HF , Sandset PM, Kolset SO, Svennevig K, et al
     Associations between regulators of extracellular matrix and hemostatic factors in hematologic neoplasias.
     Leuk Lymphoma. 2011;52:1157-9.
     PubMed     Text format     Related articles   
     
     
     
     May 2011
158. DE MELLO CA , De Andrade VP, De Lima VC, Carvalho AL, et al
     Prognostic impact of MUM1 expression by immunohistochemistry on primary mediastinal large B-cell lymphoma.
     Leuk Lymphoma. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
159. SPURGEON SE , Pindyck T, Okada C, Chen Y, et al
     Cladribine plus rituximab is an effective therapy for newly diagnosed mantle cell lymphoma.
     Leuk Lymphoma. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
160. DELL'OLIO M , Potito Scalzulli R, Sanpaolo G, Nobile M, et al
     Non-pegylated liposomal doxorubicin (Myocet(R)) in patients with poor-risk aggressive B-cell non-Hodgkin lymphoma.
     Leuk Lymphoma. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
161. BARR PM , Friedberg JW
     Getting to the heart of the problem in treating diffuse large B-cell lymphoma.
     Leuk Lymphoma. 2011.
     PubMed     Text format     Related articles   
     
     
     
     
162. LANE AA , McAfee SL, Kennedy J, Dube C, et al
     High-dose chemotherapy with busulfan and cyclophosphamide and autologous stem cell rescue in patients with Hodgkin lymphoma.
     Leuk Lymphoma. 2011.
     PubMed     Text format     Related articles   
     
     
     
     
163. ENNISHI D , Maeda Y, Fujii N, Kondo E, et al
     Allogeneic hematopoietic stem cell transplantation for advanced extranodal natural killer/T-cell lymphoma, nasal type.
     Leuk Lymphoma. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
164. BUTSCH R , Lukas Waelti S, Schaerer S, Braun J, et al
     Intratumoral plasmacytoid dendritic cells associate with increased survival in patients with follicular lymphoma.
     Leuk Lymphoma. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
165. HWANG WY , Piu Koh L, Lim ST, Ching Linn Y, et al
     Multicenter study of comparative outcomes of hematopoietic stem cell transplant for peripheral T cell lymphoma and natural killer/T-cell lymphoma.
     Leuk Lymphoma. 2011.
     PubMed     Text format     Related articles   
     
     
     
     
166. WITZIG TE , Fishkin P, Gordon LI, Gregory SA, et al
     Treatment recommendations for radioimmunotherapy in follicular lymphoma: a consensus conference report.
     Leuk Lymphoma. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
167. KENKRE VP , Long WL, Eickhoff JC, Blank JH, et al
     Maintenance rituximab following induction chemo-immunotherapy for mantle cell lymphoma: long-term follow-up of a pilot study from the Wisconsin Oncology Network.
     Leuk Lymphoma. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
168. TSAI DE , Chong E, Bagg A, Arnoldi S, et al
     Successful treatment of angioimmunoblastic T-cell lymphoma with the retinoid X receptor agonist, bexarotene.
     Leuk Lymphoma. 2011.
     PubMed     Text format     Related articles   
     
     
     
     
169. BURNELLI R , Fabbri E, Guerrini G, Sperli D, et al
     Neurological presentation of Hodgkin lymphoma in the Italian Association of Pediatric Hematology and Oncology LH-2004 protocol.
     Leuk Lymphoma. 2011.
     PubMed     Text format     Related articles   
     
     
     
     
170. LEAK A , Mayer DK, Smith S
     Quality of life domains among non-Hodgkin lymphoma survivors: an integrative literature review.
     Leuk Lymphoma. 2011.
     PubMed     Text format     Related articles   
     
     
     
     
171. STRAUS DJ
     Recent results of treatment of early stage Hodgkin lymphoma: risk-adapted approaches.
     Leuk Lymphoma. 2011;52:738-9.
     PubMed     Text format     Related articles   
     
     
     
     
172. TAM CS , Seymour JF
     Fludarabine, cyclophosphamide, and rituximab chemotherapy followed by rituximab maintenance in follicular lymphoma: high efficacy may come at a cost?
     Leuk Lymphoma. 2011;52:729-31.
     PubMed     Text format     Related articles   
     
     
     
     
173. SIRINIAN C , Symeonidis A, Giannakoulas N, Zolota V, et al
     Overexpression of phosphorylated p27 Kip1 at threonine 187 may predict outcome in aggressive B-cell lymphomas.
     Leuk Lymphoma. 2011;52:814-22.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
174. IZYKOWSKA K , Przybylski GK
     Genetic alterations in Sezary syndrome.
     Leuk Lymphoma. 2011;52:745-53.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
175. NARAYANSINGH R , Ouellette RJ
     Paired box gene 5 may modulate Proviral Integration of Moloney virus 2 gene and protein expression in mature B-cells.
     Leuk Lymphoma. 2011;52:887-95.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     April 2011
176. BHEDA A , Yue W, Gullapalli A, Shackelford J, et al
     PU.1-dependent regulation of UCH L1 expression in B-lymphoma cells.
     Leuk Lymphoma. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
177. LUIGI ZINZANI P , Pellegrini C, Broccoli A, Stefoni V, et al
     Lenalidomide monotherapy for relapsed/refractory peripheral T-cell lymphoma not otherwise specified.
     Leuk Lymphoma. 2011.
     PubMed     Text format     Related articles   
     
     
     
     
178. GUILLEM VM , Arbona C, Carlos Hernandez-Boluda J, Jose Terol M, et al
     An XRCC1 polymorphism is associated with the outcome of patients with lymphoma undergoing autologous stem cell transplant.
     Leuk Lymphoma. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
179. GEIERSBACH K , Salama M, Sennett MD, Shetty S, et al
     Multi-hit lymphoma with intermediate features and novel t(3;8)(q27;q24) not involving MYC.
     Leuk Lymphoma. 2011.
     PubMed     Text format     Related articles   
     
     
     
     
180. BUCKSTEIN R , Kuruvilla J, Chua N, Lee C, et al
     Sunitinib in relapsed or refractory diffuse large B-cell lymphoma: a clinical and pharmacodynamic phase II multicenter study of the NCIC Clinical Trials Group.
     Leuk Lymphoma. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
181. UMEMOTO T , Watanabe T, Ogose T, Kondo R, et al
     Capillary leak syndrome: initial presentation in a patient with ALK+ anaplastic large cell lymphoma associated with increased levels of serum cytokines.
     Leuk Lymphoma. 2011.
     PubMed     Text format     Related articles   
     
     
     
     
182. MAEDA LS , Lee M, Advani RH
     Current concepts and controversies in the management of early stage Hodgkin lymphoma.
     Leuk Lymphoma. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
183. HEUTTE N , Haioun C, Feugier P, Coiffier B, et al
     Quality of life in 269 patients with poor-risk diffuse large B-cell lymphoma treated with rituximab versus observation after autologous stem cell transplant.
     Leuk Lymphoma. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
184. DAVIS RE , Westin JR
     Vive la resistance: stem cells in mantle cell lymphoma.
     Leuk Lymphoma. 2011.
     PubMed     Text format     Related articles   
     
     
     
     
185. ROLLAND D , Bouamrani A, Houlgatte R, Barbarat A, et al
     Identification of proteomic signatures of mantle cell lymphoma, small lymphocytic lymphoma, and marginal zone lymphoma biopsies by surface enhanced laser desorption/ionization-time of flight mass spectrometry.
     Leuk Lymphoma. 2011;52:648-58.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
186. KASAHARA S , Hara T, Tsurumi H, Goto N, et al
     Phase II study of the tetrahydropyranyl adriamycin-cyclophosphamide, vincristine, and prednisolone regimen combined with rituximab as first-line treatment for elderly patients with diffuse large B-cell lymphoma.
     Leuk Lymphoma. 2011;52:629-34.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
187. BORCHMANN P , Herbrecht R, Wilhelm M, Morschhauser F, et al
     Phase I/II study of pixantrone in combination with cyclophosphamide, vincristine, and prednisone in patients with relapsed aggressive non-Hodgkin lymphoma.
     Leuk Lymphoma. 2011;52:620-628.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
188. GALLAMINI A , O'Doherty M
     Report of satellite workshop on interim-PET in Hodgkin lymphoma: 8th International Symposium on Hodgkin Lymphoma, Cologne, 23 October 2010.
     Leuk Lymphoma. 2011;52:583-6.
     PubMed     Text format     Related articles   
     
     
     
     
189. HUTCHINGS M
     Routine follow-up scanning of patients with lymphoma: who, when, how, and why?
     Leuk Lymphoma. 2011;52:552-3.
     PubMed     Text format     Related articles   
     
     
     
     
190. RULE S
     Velcade combinations in mantle cell lymphoma: are we learning anything?
     Leuk Lymphoma. 2011;52:545-7.
     PubMed     Text format     Related articles   
     
     
     
     
191. ROSENBLUM M , McLaughlin P
     The pharmacokinetic fate of an immunotoxin: HAMA, HARA, ding, ding, dong.
     Leuk Lymphoma. 2011;52:550-1.
     PubMed     Text format     Related articles   
     
     
     
     
192. HERBERT K , Ritchie DS
     The Goldilocks conundrum: how much granulocyte colony-stimulating factor following autologous stem cell transplant is 'just right'?
     Leuk Lymphoma. 2011;52:548-9.
     PubMed     Text format     Related articles   
     
     
     
     March 2011
193. KRISHNA R , Byrne E, Burbridge J, Salooja N, et al
     The Hammersmith hospital hematopathology case of the month: hemophagocytic lymphohistiocytosis secondary to Epstein-Barr virus associated T-cell lymphoma.
     Leuk Lymphoma. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
194. SUMMERS TA , Jaffe ES
     Hairy cell leukemia diagnostic criteria and differential diagnosis.
     Leuk Lymphoma. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
195. FERRA C , Moreno De Guzmao B, Morgades M, Lacoma A, et al
     Lack of impact of human immunodeficiency virus infection on the outcome of lymphoma patients transferred to the intensive care unit.
     Leuk Lymphoma. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
196. WANNESSON L , Luthi F, Zucca E, Rosselet-Christ A, et al
     Pegfilgrastim to accelerate neutrophil engraftment following peripheral blood stem cell transplant and reduce the duration of neutropenia, hospitalization, and use of intravenous antibiotics: a phase II study in multiple myeloma and lymphoma and compa
     Leuk Lymphoma. 2011;52:436-43.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
197. LI YX , Wang H, Feng XL, Liu QF, et al
     Immunophenotypic characteristics and clinical relevance of CD56+ and CD56- extranodal nasal-type natural killer/T-cell lymphoma.
     Leuk Lymphoma. 2011;52:417-24.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
198. KOUROUKIS CT , Fernandez LA, Crump M, Chua NS, et al
     A phase II study of bortezomib and gemcitabine in relapsed mantle cell lymphoma from the National Cancer Institute of Canada Clinical Trials Group (IND 172).
     Leuk Lymphoma. 2011;52:394-9.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
199. DELABIE J , Brodtkorb-Eide M
     Diffuse large B-cell lymphoma cycling off the main track.
     Leuk Lymphoma. 2011;52:358-9.
     PubMed     Text format     Related articles   
     
     
     
     
200. SWEETENHAM JW , Freedman AS
     Early initial therapy of advanced follicular lymphoma: the need for vigilance.
     Leuk Lymphoma. 2011;52:355-7.
     PubMed     Text format     Related articles   
     
     
     
     
201. KAN E , Levi I, Benharroch D
     Alterations in the primary diagnosis of lymphomas pretreated with corticosteroid agents.
     Leuk Lymphoma. 2011;52:425-8.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
202. HAMILTON AS
     Quality of life research: adding an important dimension to the evaluation of therapeutic outcomes.
     Leuk Lymphoma. 2011;52:353-4.
     PubMed     Text format     Related articles   
     
     
     
     
203. KAUFMAN JL , Lonial S
     Putting the E (evidence) in a new Era for myeloma.
     Leuk Lymphoma. 2011;52:349-50.
     PubMed     Text format     Related articles   
     
     
     
     
204. MOISE L , Matta C, Hanna C, Pilorge S, et al
     Methotrexate- and/or cytarabine-based chemotherapy may be effective and safe in solid-organ transplant recipients with primary central nervous system lymphomas.
     Leuk Lymphoma. 2011;52:521-4.
     PubMed     Text format     Related articles   
     
     
     
     
205. KARPOVA MB , Fujii K, Jenni D, Dummer R, et al
     Evaluation of lymphangiogenic markers in Sezary syndrome.
     Leuk Lymphoma. 2011;52:491-501.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     February 2011
206. BAECKLUND E , Backlin C, Mansouri M, Klareskog L, et al
     LMO2 protein expression predicts survival in patients with rheumatoid arthritis and diffuse large B-cell lymphoma.
     Leuk Lymphoma. 2011.
     PubMed     Text format     Related articles   
     
     
     
     
207. YAMADA K , Maeshima AM, Taniguchi H, Kawabata Y, et al
     Follicular lymphoma with marked monocytoid or plasmacytoid differentiation and tiny or indistinct follicles: a case study of four patients.
     Leuk Lymphoma. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
208. MIAN M , Gaidano G, Conconi A, Tsang R, et al
     High response rate and improvement of long-term survival with combined treatment modalities in patients with poor-risk primary thyroid diffuse large B-cell lymphoma: an International Extranodal Lymphoma Study Group and Intergruppo Italiano Linfomi stu
     Leuk Lymphoma. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
209. HAIOUN C , Salar A, Pettengell R, Erik Johnsen H, et al
     Anemia and erythropoiesis-stimulating agent administration in patients with non-Hodgkin lymphoma treated with cyclophosphamide, doxorubicin, vincristine, and prednisolone +/- rituximab chemotherapy: results from an observational study.
     Leuk Lymphoma. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
210. LINK BK , Brooks J, Wright K, Pan X, et al
     Diffuse large B-cell lymphoma in the elderly: diffusion of treatment with rituximab and survival advances with and without anthracyclines.
     Leuk Lymphoma. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
211. MAXWELL SA , Cherry EM, Bayless KJ
     Akt, 14-3-3zeta, and vimentin mediate a drug-resistant invasive phenotype in diffuse large B-cell lymphoma.
     Leuk Lymphoma. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
212. WIRTH A , Grigg A, Wolf M, Goldstein D, et al
     Risk and response adapted therapy for early stage Hodgkin lymphoma: a prospective multicenter study of the Australasian Leukaemia and Lymphoma Group/Trans-Tasman Radiation Oncology Group.
     Leuk Lymphoma. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
213. EL-GALALY T , Prakash V, Christiansen I, Madsen J, et al
     Efficacy of routine surveillance with positron emission tomography/computed tomography in aggressive non-Hodgkin lymphoma in complete remission: status in a single center.
     Leuk Lymphoma. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
214. SHIRATORI S , Kondo T, Fujisawa S, Kubota K, et al
     c-myc rearrangement in B-cell lymphoblastic lymphoma with the involvement of multiple extranodal lesions.
     Leuk Lymphoma. 2011.
     PubMed     Text format     Related articles   
     
     
     
     
215. HILL BT , Rybicki L, Smith S, Dean R, et al
     Treatment with hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone combined with cytarabine and methotrexate results in poor mobilization of peripheral blood stem cells in patients with mantle cell lymphoma.
     Leuk Lymphoma. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
216. PETTENGELL R , Schwenkglenks M
     Incidence of neutropenia, chemotherapy delivery, and use of colony-stimulating factor in patients with non-Hodgkin lymphoma of different age groups.
     Leuk Lymphoma. 2011.
     PubMed     Text format     Related articles   
     
     
     
     
217. PAPALAS JA , Sebastian S, Wang E
     Molecular evidence of a genotypically novel large T-cell lymphoma after anti-CD4 therapy for refractory mycosis fungoides.
     Leuk Lymphoma. 2011.
     PubMed     Text format     Related articles   
     
     
     
     
218. 
     Reviewers for Leukemia & Lymphoma during 2010.
     Leuk Lymphoma. 2011;52:345-8.
     PubMed     Text format     Related articles   
     
     
     
     
219. KIM JA , Kim SJ, Do IG, Jin J, et al
     Hypoxia-associated protein expression in primary central nervous system diffuse large B-cell lymphoma: does it predict prognosis?
     Leuk Lymphoma. 2011;52:205-13.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
220. MORGENSZTERN D , Walker GR, Koniaris LG, Lossos IS, et al
     Lack of survival improvement in patients with peripheral T-cell lymphoma: a Surveillance, Epidemiology, and End Results analysis.
     Leuk Lymphoma. 2011;52:194-204.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
221. GISSELBRECHT C
     A revival: radioimmunotherapy in mucosa associated lymphoid tissue lymphoma.
     Leuk Lymphoma. 2011;52:159-60.
     PubMed     Text format     Related articles   
     
     
     
     
222. VELA-CHAVEZ T , Adam P, Kremer M, Bink K, et al
     Cyclin D1 positive diffuse large B-cell lymphoma is a post-germinal center-type lymphoma without alterations in the CCND1 gene locus.
     Leuk Lymphoma. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
223. VAN DEN BERG H
     Asparaginase revisited.
     Leuk Lymphoma. 2011;52:168-78.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     January 2011
224. QIAN J , Xiao C, Yu W, Wang H, et al
     Mantle cell lymphoma in a mother and her daughter.
     Leuk Lymphoma. 2011.
     PubMed     Text format     Related articles   
     
     
     
     
225. TOMAS JF , Montalban C, De Sevilla AF, Martinez-Lopez J, et al
     Frontline treatment of follicular lymphoma with fludarabine, cyclophosphamide, and rituximab followed by rituximab maintenance: toxicities overcome its high antilymphoma effect. Results from a Spanish Cooperative Trial (LNHF-03).
     Leuk Lymphoma. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
226. NINAN MJ , Wadhwa PD, Gupta P
     Prognostication of diffuse large B-cell lymphoma in the rituximab era.
     Leuk Lymphoma. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
227. FURMAN RR , Grossbard ML, Johnson JL, Pecora AL, et al
     A phase III study of anti-B4-blocked ricin as adjuvant therapy post-autologous bone marrow transplant: CALGB 9254.
     Leuk Lymphoma. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
228. DREYLING M , Polliack A, Tadmor T
     Chlorambucil in indolent mantle cell lymphoma - just another old drug for a new disease?
     Leuk Lymphoma. 2011.
     PubMed     Text format     Related articles   
     
     
     
     
229. TAI WM , Quah D, Peng Yap S, Huey Tan S, et al
     Primary mediastinal large B-cell lymphoma: optimal therapy and prognostic factors in 41 consecutive Asian patients.
     Leuk Lymphoma. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
230. SCHMID-WENDTNER MH , Hinz T, Wenzel J, Wendtner CM, et al
     Real time tissue elastography for diagnosis of cutaneous T-cell lymphoma.
     Leuk Lymphoma. 2011.
     PubMed     Text format     Related articles   
     
     
     
     
231. FUJITA N , Kobayashi R, Takimoto T, Nakagawa A, et al
     Results of the Japan Association of Childhood Leukemia Study (JACLS) NHL-98 protocol for the treatment of B-cell non-Hodgkin lymphoma and mature B-cell acute lymphoblastic leukemia in childhood.
     Leuk Lymphoma. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
232. THOLSTRUP D , Brown PD, Jurlander J, Bekker Jeppesen P, et al
     Quality of life in patients with diffuse large B-cell lymphoma treated with dose-dense chemotherapy is only affected temporarily.
     Leuk Lymphoma. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
233. BELTRAN BE , Castillo JJ, Salas R, Quinones P, et al
     Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly treated with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone: report of two cases from South America.
     Leuk Lymphoma. 2011;52:153-6.
     PubMed     Text format     Related articles   
     
     
     
     
234. NATKUNAM Y
     T-cell lymphomas: a tale of heterogeneity masking clarity.
     Leuk Lymphoma. 2011;52:1-2.
     PubMed     Text format     Related articles   
     
     
     
     
235. VEGA MI , Baritaki S, Huerta-Yepez S, Martinez-Paniagua MA, et al
     A potential mechanism of rituximab-induced inhibition of tumor growth through its sensitization to tumor necrosis factor-related apoptosis-inducing ligand-expressing host cytotoxic cells.
     Leuk Lymphoma. 2011;52:108-21.
     PubMed     Text format     Related articles   
     
     
     
     
236. LINGARATNAM S , Thursky KA, Slavin MA
     Fluoroquinolone prophylaxis: a word of caution.
     Leuk Lymphoma. 2011;52:5-6.
     PubMed     Text format     Related articles   
     
     
     
     
237. ISIDORI A , Merli F, Angrilli F, Ferrara F, et al
     The incidence of Pneumocystis jirovecii pneumonia is not higher in patients receiving dose-dense therapy with rituximab, cyclophosphamide, non-pegylated liposomal doxorubicin, vincristine, and prednisolone and adequate Pneumocystis jirovecii pneumonia
     Leuk Lymphoma. 2011;52:148-9.
     PubMed     Text format     Related articles   
     
     
     
     
238. HSI ED , Tadmor T
     Microenvironment in peripheral T cell lymphomas: macrophages and angiogenesis as targets.
     Leuk Lymphoma. 2011;52:3-4.
     PubMed     Text format     Related articles   
     
     
     
     
239. NG ES , Liew Y, Earnest A, Koh LP, et al
     Audit of fluoroquinolone prophylaxis against chemotherapy-induced febrile neutropenia in a hospital with highly prevalent fluoroquinolone resistance.
     Leuk Lymphoma. 2011;52:131-3.
     PubMed     Text format     Related articles   
     
     
     
     December 2010
240. VOS JM , Bordbar A, Vet RJ, Pals ST, et al
     Waxing and waning intravascular large cell lymphoma with widespread organ infiltration.
     Leuk Lymphoma. 2010.
     PubMed     Text format     Related articles   
     
     
     
     
241. KENKRE VP , Horowitz S, Artz AS, Liao C, et al
     T-cell-depleted allogeneic transplant without donor leukocyte infusions results in excellent long-term survival in patients with multiply relapsed Lymphoma. Predictors for survival after transplant relapse.
     Leuk Lymphoma. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
242. JANIKOVA A , Tichy B, Supikova J, Stano-Kozubik K, et al
     Gene expression profiling in follicular lymphoma and its implication for clinical practice.
     Leuk Lymphoma. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
243. OKOSUN J , McNamara C
     Paraneoplastic peripheral blood eosinophilia in relapsed follicular lymphoma.
     Leuk Lymphoma. 2010.
     PubMed     Text format     Related articles   
     
     
     
     
244. WILLIAMS ME , Connors JM, Dreyling MH, Gascoyne RD, et al
     Mantle cell lymphoma: report of the 2010 Mantle Cell Lymphoma Consortium Workshop.
     Leuk Lymphoma. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
245. STEIN R , Balkman C, Chen S, Rassnick K, et al
     Evaluation of anti-human leukocyte antigen-DR monoclonal antibody therapy in spontaneous canine lymphoma.
     Leuk Lymphoma. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
246. HOFFMANN M , Troch M, Eidherr H, Traub-Weidinger T, et al
     (90)Y-ibritumomab tiuxetan (Zevalin) in heavily pretreated patients with mucosa associated lymphoid tissue lymphoma.
     Leuk Lymphoma. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
247. AKERS NK , Curry JD, Conde L, Bracci PM, et al
     Association of HLA-DQB1 alleles with risk of follicular lymphoma.
     Leuk Lymphoma. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
248. SACHANAS S , Pangalis GA, Vassilakopoulos TP, Korkolopoulou P, et al
     Combination of rituximab with chlorambucil as first line treatment in patients with mantle cell lymphoma: a highly effective regimen.
     Leuk Lymphoma. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     November 2010
249. ZHANG W , Wang L, Zhou D, Cui Q, et al
     Expression of tumor-associated macrophages and vascular endothelial growth factor correlates with poor prognosis of peripheral T-cell lymphoma, not otherwise specified.
     Leuk Lymphoma. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
250. MEIGNAN M , Gallamini A, Haioun C, Polliack A, et al
     Report on the Second International Workshop on interim positron emission tomography in lymphoma held in Menton, France, 8-9 April 2010.
     Leuk Lymphoma. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
251. YI JH , Kim SJ, Ko YH, Kim WS, et al
     Treatment of patients with refractory diffuse large B-cell lymphoma or mantle cell lymphoma with alemtuzumab, alone or in combination with cytotoxic chemotherapy.
     Leuk Lymphoma. 2010.
     PubMed     Text format     Related articles   
     
     
     
     
252. GALIMBERTI S , Nagy B, Ciancia E, Caracciolo F, et al
     Outcome of patients with mantle cell lymphoma is not influenced by vascular endothelial growth factor polymorphisms.
     Leuk Lymphoma. 2010.
     PubMed     Text format     Related articles   
     
     
     
     
253. BAZZEH F , Rihani R, Howard S, Sultan I, et al
     Comparing adult and pediatric Hodgkin lymphoma in the Surveillance, Epidemiology and End Results Program, 1988-2005: an analysis of 21 734 cases.
     Leuk Lymphoma. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
254. LIN HN , Liu CY, Hong YC, Pai JT, et al
     Clinical features and prognostic factors of angioimmunoblastic T-cell lymphoma in Taiwan: a single-institution experience.
     Leuk Lymphoma. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
255. BORCHMANN P
     Caring beyond cure: quality of life after high-dose chemotherapy for patients with relapsed Hodgkin lymphoma.
     Leuk Lymphoma. 2010;51:1949-50.
     PubMed     Text format     Related articles   
     
     
     
     
256. TADMOR T , Polliack A, Sweetenham J
     Ocular adnexal mucosa-associated lymphoid tissue lymphomas: more clues but still a puzzle.
     Leuk Lymphoma. 2010;51:1951-3.
     PubMed     Text format     Related articles   
     
     
     
     October 2010
257. LOURENCO GJ , Lorand-Metze I, Delamain MT, Miranda EC, et al
     Polymorphisms of glutathione S-transferase mu 1, theta 1, and pi 1 genes and prognosis in Hodgkin lymphoma.
     Leuk Lymphoma. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
258. HANZAWA K , Momose S, Higashi M, Tokuhira M, et al
     Y-box binding protein-1 expression in diffuse large B-cell lymphoma: an impact on prognosis in the rituximab era.
     Leuk Lymphoma. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
259. COOPER AR , Burack WR, Allerton JP
     A case of Kaposi sarcoma-associated herpesvirus/human herpesvirus 8-unrelated but Epstein–Barr virus-positive primary effusion lymphoma-like lymphoma in the setting of human immunodeficiency virus and hepatitis C virus infection.
     Leuk Lymphoma. 2010.
     PubMed     Text format     Related articles   
     
     
     
     
260. XICOY B , Ribera JM, Mate JX, Tapia G, et al
     Immunohistochemical expression profile and prognosis in patients with diffuse large B-cell lymphoma with or without human immunodeficiency virus infection.
     Leuk Lymphoma. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
261. YANG J , Zhang F, Fang H, Ye Z, et al
     Clinicopathologic features of primary lymphoma in soft tissue.
     Leuk Lymphoma. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
262. LJ LAZAREVIC V , H X00e4 Gglund H, Remberger M, Wahlin A, et al
     Long-term survival following allogeneic or syngeneic stem cell transplant for follicular lymphoma in Sweden.
     Leuk Lymphoma. 2010.
     PubMed     Text format     Related articles   
     
     
     
     
263. JOHANSSON AS , Nor X00e9 N-Nystr X00f6 M U, Larefalk XC, Holmberg D, et al
     Fish oil delays lymphoma progression in the TLL mouse.
     Leuk Lymphoma. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
264. PROVENCIO M , Mart X00ed N P, Garc X00ed A V, Candia A, et al
     Caspase 3a: new prognostic marker for diffuse large B-cell lymphoma in the rituximab era.
     Leuk Lymphoma. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
265. XU W , Li JY
     SOX11 expression in mantle cell lymphoma.
     Leuk Lymphoma. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
266. CASTILLO JJ , Winer ES, Stachurski D, Perez K, et al
     Clinical and pathological differences between human immunodeficiency virus-positive and human immunodeficiency virus-negative patients with plasmablastic lymphoma.
     Leuk Lymphoma. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
267. HASHIMOTO K , Kobayashi Y, Asakura Y, Mori M, et al
     Pneumocystis jiroveci pneumonia in relation to CD4+ lymphocyte count in patients with B-cell non-Hodgkin lymphoma treated with chemotherapy.
     Leuk Lymphoma. 2010;51:1816-21.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     September 2010
268. YANG H , Wu M, Yin W, Sun W, et al
     Diagnosis and treatment of a patient with primary gastric extranodal natural killer/T-cell lymphoma, nasal type.
     Leuk Lymphoma. 2010.
     PubMed     Text format     Related articles   
     
     
     
     
269. PELLISSERY S , Richter J, Haake A, Montesinos-Rongen M, et al
     Somatic mutations altering Tyr641 of EZH2 are rare in primary central nervous system lymphoma.
     Leuk Lymphoma. 2010.
     PubMed     Text format     Related articles   
     
     
     
     
270. MACDONALD DH , Clark I, Naresh KN
     The Hammersmith Hospital hematopathology case of the month: paraspinal B lymphoblastic lymphoma - problems in diagnosis and initial indolent behavior.
     Leuk Lymphoma. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
271. BRANDT J , Dietrich S, Meissner J, Neben K, et al
     Quality of life of long-term survivors with Hodgkin lymphoma after high-dose chemotherapy, autologous stem cell transplantation, and conventional chemotherapy.
     Leuk Lymphoma. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
272. CASTILLO JJ , Morales D, Quinones P, Cotrina E, et al
     Lymphopenia as a prognostic factor in patients with peripheral T-cell lymphoma, unspecified.
     Leuk Lymphoma. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
273. TADMOR T , Polliack A
     Lymphopenia a simple prognostic factor in lymphoma and other cancers: why not use it more as a guide?
     Leuk Lymphoma. 2010.
     PubMed     Text format     Related articles   
     
     
     
     
274. WONG WS , Liu BW, Lam FS, Wong KF, et al
     ALK-negative anaplastic large cell lymphoma in leukemic phase with near-pentaploidy.
     Leuk Lymphoma. 2010.
     PubMed     Text format     Related articles   
     
     
     
     
275. NIPARUCK P , Kanoksil W, Chuncharunee S, Boonsakan P, et al
     Therapy-related myelodysplastic syndrome/acute myeloid leukemia following fludarabine therapy for non-Hodgkin lymphoma and chronic lymphocytic leukemia in Thai patients.
     Leuk Lymphoma. 2010.
     PubMed     Text format     Related articles   
     
     
     
     
276. LIU YY , Yao SN, Zhao Y, Yao ZH, et al
     PTEN tumor suppressor plays less prognostic role than P53 tumor suppressor in diffuse large B-cell lymphoma.
     Leuk Lymphoma. 2010;51:1692-8.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
277. LI X , Lin Q, Dong M, Wen JY, et al
     Prognostic analysis of acute exacerbations of hepatitis-B after chemotherapy in combination with rituximab in 19 patients with lymphoma.
     Leuk Lymphoma. 2010;51:1678-85.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
278. MOREL P , Munck JN, Coiffier B, Gisselbrecht C, et al
     Comparison of two high-dose cyclophosphamide, doxorubicin, vincristine, and prednisone derived regimens in patients aged under 60 years with low-intermediate risk aggressive lymphoma: a final analysis of the multicenter LNH93-2 protocol.
     Leuk Lymphoma. 2010;51:1668-77.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
279. JONES JA , Fayad LE, Elting LS, Rodriguez MA, et al
     Body mass index and outcomes in patients receiving chemotherapy for intermediate-grade B-cell non-Hodgkin lymphoma.
     Leuk Lymphoma. 2010;51:1649-57.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
280. NAVARRO WH , Loberiza FR
     Obesity and lymphoma therapy: not a bad combination after all.
     Leuk Lymphoma. 2010;51:1590-1.
     PubMed     Text format     Related articles   
     
     
     
     
281. DELABIE J
     Prognostic markers in diffuse large B-cell lymphoma.
     Leuk Lymphoma. 2010;51:1588-9.
     PubMed     Text format     Related articles   
     
     
     
     
282. HUI D , Proctor B, Donaldson J, Shenkier T, et al
     Prognostic implications of extranodal involvement in patients with diffuse large B-cell lymphoma treated with rituximab and cyclophosphamide, doxorubicin, vincristine, and prednisone.
     Leuk Lymphoma. 2010;51:1-10.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
283. DUNLEAVY K , Wilson WH
     Targeting CD52 as a novel therapeutic strategy in angioimmunoblastic T-cell lymphoma.
     Leuk Lymphoma. 2010;51:1-2.
     PubMed     Text format     Related articles   
     
     
     
     
284. THOMPSON PA , Tam CS, Thursky K, Seymour JF, et al
     Hepatitis-B reactivation and rituximab-containing chemotherapy: an increasingly complex clinical challenge.
     Leuk Lymphoma. 2010;51:1592-5.
     PubMed     Text format     Related articles   
     
     
     
     August 2010
285. ZHANG D , Dong L, Li H, Jin H, et al
     Ocular adnexal mucosa-associated lymphoid tissue lymphoma in Northern China: high frequency of numerical chromosomal changes and no evidence of an association with Chlamydia psittaci.
     Leuk Lymphoma. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
286. BARROS MH , Scheliga A, De Matteo E, Minnicelli C, et al
     Cell cycle characteristics and Epstein-Barr virus are differentially associated with aggressive and non-aggressive subsets of Hodgkin lymphoma in pediatric patients.
     Leuk Lymphoma. 2010;51:1513-26.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
287. MALONEY D , Morschhauser F, Linden O, Hagenbeek A, et al
     Diversity in antibody-based approaches to non-Hodgkin lymphoma.
     Leuk Lymphoma. 2010;51 Suppl 1:20-7.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
288. GASCOYNE RD , Rosenwald A, Poppema S, Lenz G, et al
     Prognostic biomarkers in malignant lymphomas.
     Leuk Lymphoma. 2010;51 Suppl 1:11-9.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
289. CZUCZMAN M , Straus D, Gribben J, Bredenfeld H, et al
     Management options, survivorship, and emerging treatment strategies for follicular and Hodgkin lymphomas.
     Leuk Lymphoma. 2010;51 Suppl 1:41-9.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     July 2010
290. DUNLEAVY K , Mikhaeel G, Sehn LH, Hicks RJ, et al
     The value of positron emission tomography in prognosis and response assessment in non-Hodgkin lymphoma.
     Leuk Lymphoma. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
291. WILSON WH , Hernandez-Ilizaliturri FJ, Dunleavy K, Little RF, et al
     Novel disease targets and management approaches for diffuse large B-cell lymphoma.
     Leuk Lymphoma. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
292. HWANG DW , Lim CS, Jang JY, Lee SE, et al
     Primary hematolymphoid malignancies involving the extrahepatic bile duct or gallbladder.
     Leuk Lymphoma. 2010;51:1278-87.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     June 2010
293. CONCONI A , Motta M, Bertoni F, Piona C, et al
     Patterns of survival of follicular lymphomas at a single institution through three decades.
     Leuk Lymphoma. 2010;51:1028-34.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
294. MACHADO AS , Da Silva Robaina MC, Magalhaes De Rezende LM, Apa AG, et al
     Circulating cell-free and Epstein-Barr virus DNA in pediatric B-non-Hodgkin lymphomas.
     Leuk Lymphoma. 2010;51:1020-7.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
295. CZUCZMAN MS , Gregory SA
     The future of CD20 monoclonal antibody therapy in B-cell malignancies.
     Leuk Lymphoma. 2010;51:983-94.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     May 2010
296. POIRE X , Kline J, Grinblatt D, Zimmerman T, et al
     Phase II study of immunomodulation with granulocyte-macrophage colony-stimulating factor, interleukin-2, and rituximab following autologous stem cell transplant in patients with relapsed or refractory lymphomas.
     Leuk Lymphoma. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
297. ZHANG D
     Histiocytic sarcoma arising from lymphomas via transdifferentiation pathway during clonal evolution.
     Leuk Lymphoma. 2010;51:739-40.
     PubMed     Text format     Related articles   
     
     
     
     
298. WATANABE T , Kinoshita T, Itoh K, Yoshimura K, et al
     Pretreatment total serum protein is a significant prognostic factor for the outcome of patients with peripheral T/natural killer-cell lymphomas.
     Leuk Lymphoma. 2010;51:813-21.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
299. KAMEL S , O'Connor S, Lee N, Filshie R, et al
     High incidence of Pneumocystis jirovecii pneumonia in patients receiving biweekly rituximab and cyclophosphamide, adriamycin, vincristine, and prednisone.
     Leuk Lymphoma. 2010;51:797-801.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
300. GOLDENBERG DM , Morschhauser F, Wegener WA
     Veltuzumab (humanized anti-CD20 monoclonal antibody): characterization, current clinical results, and future prospects.
     Leuk Lymphoma. 2010;51:747-55.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     April 2010
301. MARTIN P
     When 18-fluorodeoxyglucose-positron emission tomography is indeterminate, the International Prognostic Index is the answer.
     Leuk Lymphoma. 2010;51:569-70.
     PubMed     Text format     Related articles   
     
     
     
     
302. CHEN YL , Su IJ, Cheng HY, Chang KC, et al
     BIOMED-2 protocols to detect clonal immunoglobulin and T-cell receptor gene rearrangements in B- and T-cell lymphomas in southern Taiwan.
     Leuk Lymphoma. 2010;51:650-5.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     March 2010
303. WEIDMANN E , Hess G, Chow KU, Krause SW, et al
     A phase II study of alemtuzumab, fludarabine, cyclophosphamide, and doxorubicin (Campath-FCD) in peripheral T-cell lymphomas.
     Leuk Lymphoma. 2010;51:447-55.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
304. MOLICA S
     A systematic review on Richter syndrome: what is the published evidence?
     Leuk Lymphoma. 2010;51:415-21.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
305. VULSTEKE C , Dierickx D, Verbeken E, Wolter P, et al
     Rituximab-induced fatal interstitial pneumonitis: case report.
     Leuk Lymphoma. 2010;51:546-8.
     PubMed     Text format     Related articles   
     
     
     
     
306. JOHNSTON A , Bouafia-Sauvy F, Broussais-Guillaumot F, Michallet AS, et al
     Retreatment with rituximab in 178 patients with relapsed and refractory B-cell lymphomas: a single institution case control study.
     Leuk Lymphoma. 2010;51:399-405.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
307. JAYASEKARA H , Karahalios A, Juneja S, Thursfield V, et al
     Incidence and survival of lymphohematopoietic neoplasms according to the World Health Organization classification: a population-based study from the Victorian Cancer Registry in Australia.
     Leuk Lymphoma. 2010;51:456-68.
     PubMed     Text format     Related articles    Abstract available
     
     
     

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: